Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors.
Chen G, Zhu X, Li J, Zhang Y, Wang X, Zhang R, Qin X, Chen X, Wang J, Liao W, Wu Z, Lu L, Wu W, Yu H, Ma L.
Chen G, et al. Among authors: yu h.
Pharmacol Res. 2022 Nov;185:106487. doi: 10.1016/j.phrs.2022.106487. Epub 2022 Oct 3.
Pharmacol Res. 2022.
PMID: 36202184
Free article.